The historical rank and industry rank for Transgenic Group's Pretax Margin % or its related term are showing as below:
TSE:2342'
s Pretax Margin % Range Over the Past 10 Years
Min: -5.2 Med: 0.37 Max: 22.01
Current: -1.58
TSE:2342's Pretax Margin % is ranked better than 70.36% of 938
companies
in the Biotechnology industry
Industry Median: -89.895
vs TSE:2342: -1.58
Transgenic Group (TSE:2342) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Transgenic Group Pretax Margin % Related Terms
Transgenic Group Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Transgenic Group's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:2342 vs VRTX, REGN, ALNY: Pretax Margin % Comparison
For the Biotechnology subindustry, Transgenic Group's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Transgenic Group Pretax Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Transgenic Group's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Transgenic Group's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Transgenic Group (TSE:2342) has a Pretax Margin % of -3.80% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Transgenic Group and its competitors. According to the industry distribution chart, Transgenic Group ranks #278 out of 938 companies in the Biotechnology industry, placing it in the top 29.6%.
Is Transgenic Group's Pretax Margin % too high?
Transgenic Group's current Pretax Margin % is -3.80%. Based on the distribution chart, Transgenic Group ranks #278 out of 938 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Transgenic Group has a GF Score™ of 60/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Transgenic Group's Pretax Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Transgenic Group ranks #278 out of 938 companies for Pretax Margin %. This puts Transgenic Group in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Transgenic Group and its competitors. Transgenic Group's current Pretax Margin % is -3.80%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Transgenic Group stock overvalued right now?
Based on GuruFocus' analysis, Transgenic Group (TSE:2342) is currently considered Modestly Undervalued. The stock's GF Value™ is 円257.54, compared to a current price of 円220.00 — trading 14.6% below its estimated fair value. The current Pretax Margin % is -3.80%. Transgenic Group's overall GF Score™ is 60/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Transgenic Group (TSE:2342), the current Pretax Margin % is -3.80% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Transgenic Group (TSE:2342) Overvalued in 2026?
Based on GuruFocus' analysis, Transgenic Group stock appears to be undervalued.
The current stock price of 円220.00 is trading 14.6% below its estimated GF Value™ of 円257.54.
GuruFocus considers Transgenic Group to be Modestly Undervalued.
Key valuation signals for TSE:2342:
Pretax Margin %: -3.80%
GF Value™: 円257.54 vs. price of 円220.00 (14.6% below fair value)
No single metric tells the full story. See the TSE:2342 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Transgenic Group Inc formerly Trans Genic Inc is engaged in offering assistance of non-clinical experiments using large animals and general rearing management work, and non-clinical trial service using large animals. The company has two segments: Drug discovery support business, and Investment and consulting business.
60GF Score
Get the complete analysis for TSE:2342
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2342 has been successfully added to your 
